Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

Access our Services

Covid19 services

ERINHA offers access to a large range of high containment in-vitro and in-vivo capacities to facilitate a wide variety of studies on SARS-CoV-2/COVID-19.

(Update from 20.09.2020)

  • In vitro research capacity includes but is not limited to
    • standard virologic assays
    • high‑throughput SARS-CoV-2 antiviral/therapeutic screening assays
    • diagnostic development and testing capacity
    • virus propagation and quantification
    • development of new in vitro assays / methods in accordance with the User’s needs
  • In vivo research capacity includes but is not limited to:
    • Hamster disease model
    • Standard in vivo virologic and immunological assays
    • Pre-clinical vaccines and therapeutics testing
    • Development of new animal models / in vivo methods in accordance with the User’s needs
  • Additionally, ERINHA provides support for:
    • Coordination of pre-clinical research activities
    • Project management
    • Research protocols and experimental design

This video presents how 9 of the European Life Science Research Infrastructures can be used to advance research on coronavirus and other diseases.

Members

Our adress

ERINHA AISBL
98, rue du Trône / Boîte n°4
B-1050 Bruxelles

ERINHA AISBL CCU
101, rue Tolbiac – 75013 Paris

contact@erinha.eu

Extra links

Newsletters

Subscribe for latest articles and resources

©ERINHA 2021 by MLCOM / Legal mentions & Personal data protection policy